Lexeo Therapeutics, Inc. LXEO
Set alert
3.22 USD +0.15 +5.07%
As of Nov 3, 11:26 AM ET
3.01 Day range 3.30
2.55 52-week range 10.99
- YTD
- -67.62%
- 1 year
- -64.44%
- Open
- 3.10
- Prev close
- 3.06
- Mkt cap
- 263.91M
- Vol
- 284.49K
- Avg vol
- 1.31M
- EPS
- -1.02
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.01
- High
- 3.30
- Forward P/E
- -2.24
- Beta
- 0.00
- Short ratio
- 6.55
- Inst. own
- 91.48%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 9, 2024
- 50-d avg
- 7.92
- 200-d avg
- 11.86
- 1y target
- 22.29
5D chart
Signals (69)
| Name | Time | Ago |
|---|---|---|
| MACD: Sell Signal | Nov 3, 10:40 AM | 48 minutes ago |
| RSI: Overbought | Nov 3, 10:00 AM | 1 hour ago |
| RSI: Overbought | Nov 3, 9:40 AM | 1 hour ago |
| RSI: Overbought | Nov 3, 9:30 AM | 1 hour ago |
| SMA: Bullish | Nov 2, 2:55 PM | 20 hours ago |
| SMA: Bullish | Nov 2, 2:55 PM | 20 hours ago |
| MACD: Buy Signal | Nov 2, 2:55 PM | 20 hours ago |
| MACD: Sell Signal | Nov 2, 2:45 PM | 20 hours ago |
| SMA: Bearish | Nov 2, 2:30 PM | 20 hours ago |
| MACD: Buy Signal | Nov 2, 2:10 PM | 21 hours ago |
| MACD: Sell Signal | Nov 2, 1:40 PM | 21 hours ago |
| MACD: Buy Signal | Nov 2, 1:35 PM | 21 hours ago |
| SMA: Bullish | Nov 2, 1:25 PM | 22 hours ago |
| MACD: Sell Signal | Nov 2, 12:30 PM | 22 hours ago |
| SMA: Bearish | Nov 2, 12:25 PM | 23 hours ago |
| MACD: Buy Signal | Nov 2, 11:35 AM | 23 hours ago |
| SMA: Bullish | Nov 2, 11:30 AM | 23 hours ago |
| SMA: Bullish | Nov 2, 11:30 AM | 23 hours ago |
| MACD: Sell Signal | Nov 2, 10:45 AM | 1 day ago |
| MACD: Buy Signal | Nov 2, 10:20 AM | 1 day ago |
Newest 20 of 69.
Analyst view
Price target (mean) 22.29 +593.2% upside
Now 3.22
- Target (low)
- 16.00
- Target (mean)
- 22.29
- Target (high)
- 28.00
Ratings (0m) 7 7 buy · 0 hold · 0 sell
- Strong buy3
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 6
- 2 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.77664 | -0.90 – -0.60986 | 0.00 | 0.0% | 0 | 0.0% | 6 |
| Next quarter | -0.795 | -0.93 – -0.53 | -0.77 | -3.3% | 0 | 0.0% | 4 |
| Current year | -2.75 | -3.01 – -2.55 | -12.30 | +77.6% | 0 | 0.0% | 6 |
| Next year | -3.01 | -3.84 – -1.79 | -2.75 | -9.4% | 750.00K | 0.0% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 14, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 13, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Nov 13, 2024 | Leerink Partners | Maintained | Outperform | Outperform |
| Oct 31, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 30, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Oct 25, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Aug 14, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Aug 13, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 13, 2024 | RBC Capital | Reiterated | Outperform | Outperform |
| Jul 16, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 15, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Jun 13, 2024 | Baird | Initiated | — | Outperform |
| Jun 6, 2024 | HC Wainwright & Co. | Initiated | — | Buy |
| Mar 12, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 28, 2023 | Chardan Capital | Initiated | — | Buy |
| Nov 28, 2023 | Leerink Partners | Initiated | — | Outperform |
| Nov 28, 2023 | RBC Capital | Initiated | — | Outperform |
| Nov 28, 2023 | Stifel | Initiated | — | Buy |
| Nov 28, 2023 | JP Morgan | Initiated | — | Overweight |